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ABSTRACT
Proteolytic cleavage of translation initiation factors
is a means to interfere with mRNA circularization
and to induce translation arrest during picornaviral
replication or apoptosis. It was shown that the
regulated cleavages of eukaryotic initiation factor
(eIF) 4G and poly(A)-binding protein (PABP) by viral
proteinases correlated with early and late arrest of
host cap-dependent and viral internal ribosome
entry site (IRES)-dependent translation, respec-
tively. Here we show that in contrast to coxsack-
ievirus, eIF4G is not a substrate of proteinase 3C of
hepatitis A virus (HAV 3C
pro). However, PABP is
cleaved by HAV 3C
pro in vitro and in vivo, separating
the N-terminal RNA-binding domain (NTD) of PABP
from the C-terminal protein-interaction domain.
In vitro, NTD has a dominant negative effect on
HAV IRES-dependent translation and an enhanced
binding affinity to the RNA structural element pY1 in
the 5’ nontranslated region of the HAV RNA that is
essential for viral genome replication. The results
point to a regulatory role of PABP cleavage in RNA
template switching of viral translation to RNA
synthesis.
INTRODUCTION
Translation initiation of capped mRNA is remarkably
stimulated by the 30 poly(A) tail. This synergistic eﬀect on
translation was attributed to interactions between the
eukaryotic translation initiation factor (eIF) complex
eIF4F and the poly(A)-binding protein (PABP) (1–5).
eIF4F consists of the cap-binding protein eIF4E, the
ATP-dependent RNA helicase eIF4A, and eIF4G that
serves as a scaﬀold for the binding of several proteins,
including eIF4E, eIF4A and eIF3. In addition, eIF4G
contains in its N-terminal part a binding site for PABP.
The simultaneous binding of eIF4G to the cap-bound
eIF4E and PABP associated with the poly(A) tail can
bring the RNA ends in close proximity and circularize
mRNA, thereby allowing ribosome recycling (5,6).
Cytoplasmic PABP is an abundant protein of 70kDa
that has been recognized as a true translation initiation
factor (7–9). It contains four RNA recognition motifs
(RRM) in its N-terminal domain (NTD) that are involved
in RNA and eIF4G binding (10). A proline- and
glutamine-rich linker region connects the NTD to the
C-terminal domain (CTD) that interacts with various
proteins involved in both translation initiation (eIF4B,
60S ribosomal subunit) as well as termination (releasing
factor eRF3). In addition, the CTD mediates PABP
oligomerization that contributes to the cooperative bind-
ing to poly(A) sequences longer than 12 residues. Besides
its function in translation, PABP controls mRNA stability
and plays additional roles in the regulation of gene
expression (11,12).
Picornaviruses have a messenger-sense RNA genome of
 7500 bases, with a large open reading frame that is
ﬂanked by 50 and 30 nontranslated regions (NTR) and
terminated by a poly(A) tail of more than 60 residues. In
place of the cap structure, the 50 end of the viral genome is
covalently attached to the small protein VPg that is the
primer of RNA synthesis. Replication of most picorna-
viruses in cell culture is associated with cytopathology.
These viruses have evolved various mechanisms to ensure
eﬃcient viral translation, often at the expense of host
protein synthesis. Viral proteins rearrange cell membranes
and viral proteinases impact the structure and localization
of host cell proteins. Among the identiﬁed cellular targets,
eIF4G is cleaved by poliovirus (PV) proteinase 2A or foot-
and-mouth-disease virus proteinase Lb, resulting in the
abrogation of cap-dependent translation of host mRNAs
early in infection (13–15). PABP cleavage by coxsack-
ievirus B3 (CVB3) or PV proteinases 2A
pro and 3C
pro
seems to occur later in the viral life cycle (16–19). Overall,
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down-regulate host metabolism mostly by drastically
inhibiting cellular translation, while viral translation
continues via a cap-independent mechanism.
As a member of the hepatovirus genus, the hepatitis A
virus (HAV) is genetically and phenotypically distinct
from the other members of the picornavirus family (e.g.
enterovirus, rhinovirus, cardiovirus and aphthovirus).
Whereas most other picornaviruses contain—besides the
major proteinase 3C—a second proteolytic activity in their
polyprotein, which is predominantly causing host shut-oﬀ,
the HAV polyprotein lacks such an activity. The HAV
50NTR of 734 residues comprises cis-acting elements
involved in genome replication and translation initiation.
Computer-assisted folding predictions and biochemical
probing showed that the HAV 50NTR forms extensive
higher order structures which include six stem-loop
domains [(20–25), see Figure 5 for a simpliﬁed outline of
essential parts of the HAV 50 NTR]. The 50 most terminal
domain (bases 1 to 95) contains a hairpin and two
pseudoknots and is followed by a pyrimidine-rich tract
(pY1, bases 96 to 148). These parts of the 50NTR are
involved in viral replication (26). The remainder of
the 50NTR (bases 155 to 734) functions as an internal
ribosome entry site (IRES), allowing cap-independent
translation initiation. Owing to its unique structure and
due to diverse requirements for optimal activity, the HAV
IRES (type III IRES) substantially diﬀers from the IRES
of other picornaviruses and that of the hepatitis C virus
(20,21,27,28). The HAV IRES interacts with a number of
host proteins, such as the poly(rC)-binding protein 2
(PCBP2) (29), glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) (30,31), the polypyrimidine tract-binding pro-
tein [PTB; (31,32)] and eIF4GI (27,33). The role of these
interactions is still elusive. Following uptake of the viral
messenger-sense RNA into the cell, the viral polyprotein is
synthesized through internally initiated translation at the
IRES. The HAV proteinase 3C
pro, that itself is a part of
the polyprotein, catalyzes the subsequent liberation of the
structural and nonstructural proteins. Together with host
proteins, the latter assemble into the viral replication
complex and viral RNA synthesis starts with the genera-
tion of a negative strand intermediate. As translation and
negative strand synthesis are competing processes that
proceed in opposite directions on the infecting viral
genome, the translating viral RNA must be cleared of
initiating or recycling ribosomes before RNA synthesis
can begin (34). In this context, the observation is
interesting that polioviral genomes that have not been
translated cannot function as template for RNA synthesis.
The molecular mechanisms regulating this selection of
viral RNA template functions are currently scrutinized.
Most strikingly and in sharp contrast to the cytolytic
picornaviruses, replication of most HAV strains is highly
protracted and noncytopathogenic in cell culture. One
way to ensure viral persistence in culture is the observed
suppression of cellular antiviral defense mechanism by
HAV (35). As no eﬀect on the host metabolism has been
detected so far in HAV-infected cells, it appears that HAV
remains in a state of constant competition with host
translation and never reaches a privileged stage of protein
synthesis (1,36,37). Beyond competing with host protein
synthesis, production of the HAV polyprotein clearly
conﬂicts with HAV RNA synthesis at later phases of the
viral life cycle. In particular, it is not clear how HAV
translation is stalled to allow RNA synthesis to occur. It is
tempting to speculate that once enough of the replication
complex is formed, one or several of its components
interfere with HAV translation initiation by aﬀecting
essential translation factor(s). Here, we present evidence
that—unlike the enteroviruses—HAV proteinase 3C
pro
does not cleave eIF4G. However, HAV 3C
pro cleaves
PABP in vitro and in vivo and exploits its cleavage
product. We show that the NTD of PABP has improved
RNA-binding capacity to the pY1 in the HAV 50NTR and
speciﬁcally suppresses HAV IRES translation pointing to
its regulatory function in halting viral protein synthesis.
MATERIALS AND METHODS
Plasmids and in vitrotranscription
Plasmids pET15b-3ABCwt, pET15b-3ABCm and
pET15b-3ABCm that encode various precursor forms of
HAV 3C were described before (38). pET28-hPABP
(kindly provided by M. Go ¨ rlach) encodes the complete
PABP with an N-terminal His-tag (9). pET28-PABP1234
(kindly provided by G.J. Goodall) encodes the N-terminal
domain (NTD) of PABP with four RNA-binding motifs
and a N-terminal His-tag (39). pET28-PABP-CT [kindly
provided by M. Kiledjian; (40)] encodes the His-tagged
CTD. The HAV replicon (pT7-18f-Luc-A60) was
described before (41). The poliovirus replicon pRluc31
was kindly provided by R. Andino (42). Luciferase-
encoding replicon RNA was prepared according to the
user manual of the T7 RiboMAX Large Scale RNA
production system (Promega), after linearization of the
HAV replicon cDNA with AgeI and the PV replicon with
MluI. pHAV-IRES-luc encodes the ﬁreﬂy luciferase that is
preceded by the HAV IRES (HAV nucleotides 44–736)
(3). pHAV-IRES-luc was linearized with NotI prior to
in vitro transcription with T3 RNA polymerase.
Radiolabeled RNAs was prepared as described in the
manual of the MaxiScript
TM in vitro transcription kit
(Ambion), with 3ml a-[
32P]-UTP (10mCi/ml) and addi-
tional 2ml UTP (0.05mM) in a 20ml volume. To generate
30 NTR-A20 and 3’NTR-A60 transcripts, pT7-18f-(P1-
P3)-A20 and pT7-18f-(P1-P3)-A60 were linearized
with AgeI and used as template for T7 transcription
(43). pT7-18f-(P1-P3) A0rbz was linearized with RsrII to
generate the 30 NTR-A0 transcript. To produce RNA1-94
and RNA95-148, pGEM1-HM175-1-95 and pGEM1-
HM175-95-736 were linearized with EcoRI or SspI,
respectively, and transcribed with SP6 RNA polymerase
(44). Radiolabeled RNA was puriﬁed, and dissolved in
50ml RNase-free water.
Recombinant proteins
Plasmids pET28-hPABP, pET28-PABP1234 and pET28-
PABP-CT were expressed in Escherichia coli strain BL21
(DE3) pLysS as described (39,40,45). The soluble proteins
were puriﬁed using HisTrap chelating HP columns as
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ciences, USA). The eluted proteins were concentrated
and transferred into 50mM Tris–HCl, pH 8.0, 50mM
NaCl, 15% glycerol using a centrifugal ﬁlter device
(Amicon Ultra 30 000). Puriﬁed 3C of HAV and
coxsackievirus B3 (CVB3; kind gift of R. Zell) were
described previously (45,46).
RNA–protein interaction determined by electrophoretic
mobility shiftassay(EMSA)
EMSA was essentially performed as described before
(44,47,48). [
32P]-labeled riboprobes (2.5 10
5c.p.m.) were
incubated with increasing amounts of puriﬁed PABP or
NTD(50–700nM)in15mlreactionbuﬀercontaining5mM
HEPES, (N-2-hydroxyethylpiperazine-N0-ethansulfonic
acid), pH 7.9, 25mM KCl, 2mM MgCl2, 1.75mM ATP,
6mM dithiothreitol (DTT), 0.05mM phenylmethyl-
sulfonyl ﬂuoride, 166mg/ml of E. coli tRNA, and 5%
glycerol. After 20min at 308C, the mixture was supple-
mented with 5ml of sample buﬀer (1mM EDTA,
0.25% bromophenol blue (BPB), 0.25% xylene cyanol,
50% glycerol) and analyzed by electrophoresis using a
6% nondenaturing polyacrylamide gel (PAGE).
Electrophoresis was conducted in 0.5  Tris-borate buﬀer
at 150V for 30–90min until the BPB marker had migrated
to 2/3 of the gel length. The gel was scanned using a
PhosphorImager(FujiﬁlmBAS1000,Japan)andtheimage
was analyzed with the analysis software PCBAS (Raytest,
Isotopemessgera ¨ te GmbH, Germany). The apparent equi-
librium-binding constant (app. Keq) was calculated accord-
ing to Lane et al. (49).
Proteolytic cleavage invitro
Four-hundred nanogram-puriﬁed recombinant PABP and
various amounts of HAV or CVB3 proteinases 3C
pro (ﬁnal
concentration, 1–10mM) were incubated at 378C for
6–24h in cleavage buﬀer (19). The reaction was stopped
by the addition of sodium dodecylsulfate (SDS)–PAGE
sample buﬀer and the products were analyzed by SDS–
PAGE, followed by immunoblot with anti-3C, anti-PABP
or anti-His. For cleavage of PABP and eIF4G in cell
fractions (S10, S200 and P200, see subsequently), 10mlo f
the extracts were incubated with HAV 3C
pro (7mM ﬁnal
concentration). The cleavage products were detected by
immunoblot using anti-eIF4G or anti-PABP.
Viruses and cells
HAV strain 18f was propagated in the human hepatoma
cell line Huh-7. For HAV infection, cells were inoculated
for 3h at 378C with the soluble extract of HAV-infected
cells at a multiplicity of infection (moi) of 1 tissue culture
infectious dose50/cell in OptiMEM (Invitrogen). Infected
cells were incubated in Dulbecco’s-modiﬁed Eagle
medium (DMEM) with 2% fetal calf serum for the
indicated time periods. The recombinant vaccinia virus
vTF7-3 that encodes T7 RNA polymerase was ampliﬁed
in COS-7 cells and the virus stock was plaque titrated by
serial 10-fold dilutions (50). The working dose of vTF7-3
as a helper virus to aid the expression of T7-promoted
genes was characterized by quantiﬁcation of luciferase
activity after transfection of pT7-LUC (Luciferase T7
Control DNA, Promega), followed by infection with
vTF7-3.
Proteolytic cleavage in vivo
For coexpression, Huh-T7 cells that constitutively express
T7 RNA polymerase were used (25). They were grown in
DMEM in the presence of geneticin (G-418 sulfate,
400mg/ml), penicillin (100U/ml) and streptomycin sulfate
(100mg/ml). pET28-hPABP and plasmids encoding HAV
3C
pro were cotransfected into 5 10
5 cells. The transfec-
tion mixture containing 1mg cDNA and 8ml Lipofectamin
(Invitrogen) in 200ml OptiMEM was pre-incubated for
30min at room temperature and diluted with OptiMEM
to 1ml before applying to 80% conﬂuent cells. After
incubation for 3h at 378C, transfected cells were infected
with vTF7–3 (moi  1). After 1h at 378C, the inoculum
was replaced with DMEM containing 10% fetal calf
serum and antibiotics. After incubation for 24–48h at
378C, the cells were scraped in 250ml phosphate-buﬀered
saline containing 0.05% Tween-20 and lyzed by three
cycles of freeze/thawing. The clariﬁed supernatant was
used for reporter gene detection and/or for immunoblot
analyzes with anti-PABP or anti-His-tag. To conﬁrm the
expression of viral proteinase 3C
pro, the transferred
proteins were also tested with anti-HAV 3C
pro raised
against the recombinant proteinase (46). To determine
PABP cleavage in the course of the HAV infection,
extracts of infected cells were obtained as described above
and analyzed by immunoblot with anti-PABP.
Immunological assays
After electrophoretic separation by SDS–PAGE (10 or
12% polyacrylamide) and transfer onto a nitrocellulose
membrane (Protran, Schleicher & Schuell, Bioscience), the
blots were probed either with monoclonal anti-His
(Novagen), anti-PABP or anti-eIF4G1 directed against
the peptide KKEAVGDLLDAFKEVN representing
amino acid residues 523–538 of the N-terminus [(51);
kind gift of R.E. Rhoads]. Anti-PABP was raised against a
synthetic peptide sequence (GIDDERLRKEFSPFGTC)
in the RRM4 of human PABP (kind gift of R. Lloyd). The
particle-speciﬁc enzyme-linked immunosorbent assay
(ELISA) with the monoclonal anti-HAV 7E7
(Mediagnost, Germany) and its horseradish peroxidase
conjugate were applied to detect viral particles as
described (52,53).
Preparation ofcell extracts and invitro translation
Cell extracts were prepared as described elsewhere (34,54).
In brief, Huh-7 cells at 90% conﬂuence were suspended
and harvested by centrifugation (800g,4 8C, 6min). After
washing with PBS, the cell pellet was re-suspended in 2 vol
of hypotonic buﬀer (50mM KCl, 25mM HEPES, 1.6mM
MgCl2, 1mM DTT). The suspension was allowed to swell
on ice for 15min, before lyzing with 15 strokes of a
Wheaton Douncer. Then 1/9 vol of 10  concentrated
HNG buﬀer (25mM HEPES, pH 7.5, 1M potassium
acetate, 30mM MgCl2, 30mM DTT) was added.
The debris was spun at 11000g, for 20min at 48C and
Nucleic Acids Research, 2007, Vol. 35, No. 17 5977the supernatant (S10) stored at  708C. The extract
concentration was >25 A260 U/ml. S200 and P200
(Ribo) were prepared as described (19). The 50ml in vitro
translation mixture contained 25ml S10 extract, 5ml1 0  
translation mix (125mM HEPES pH 7.3, 10mM ATP,
2mM GTP, 2mM CTP, 2mM UTP, 100mM creatine
phosphate, 0.2mM amino acids, 1mg/ml creatine phos-
phokinase), 5ml salt mix (1M potassium acetate, 30mM
MgCl2, 2.5mM spermidine), 1ml methionine (1mM), 40 U
RNase inhibitor and 1mg luciferase-encoding RNA. When
the eﬀect of PABP and its truncated versions was tested,
PABP, NTD and CTD in native and heat-denatured form
were added at the indicated amounts, before the mixtures
(prepared in at least duplicate) were incubated at 308C.
Aliquots in duplicate were taken at 90min, and luciferase
activity was tested with the Luciferase Assay System
(Promega) in the luminometer Lucy-3 of Anthos,
Germany. Luciferase activity is expressed in relative light
units (RLU).
RESULTS AND DISCUSSION
eIF4G isnot cleaved by HAV 3C
pro
To evade the cells’ antiviral machinery early on in the viral
life cycle, proteinases of some picornaviruses cleave eIF4G
that serves as scaﬀolding protein in the cap-binding
complex eIF4F (13,15). Whereas host translation is
subsequently blocked, viral IRES-mediated translation
proceeds and is even stimulated in the presence of cleaved
eIF4G (14). HAV replicates in a highly protracted and
asynchronous fashion in cells. This particular replication
feature, combined with low yields of viral progeny, was
often posed as argument that speciﬁc viral eﬀects on the
host metabolism could not be identiﬁed in HAV-infected
cells. To provide direct evidence for the unconﬁrmed
observation that eIF4G remained intact in HAV-infected
cells (14), eIF4G cleavage by the one and only HAV
proteinase 3C
pro in vitro was directly assessed. To this aim,
endogenous eIF4G of a S10 cell extract was subjected to
treatment with puriﬁed viral proteinases. After incubation
with HAV 3C
pro for 6h at 378C, no cleavage products
were detectable in the anti-eIF4G blot (Figure 1A, lower
panel, compare lanes 1 and 2). However, and in
accordance with previously reported data (16), eIF4G
was almost completely cleaved by CVB3 3C
pro (lane 3)
under the same conditions. Moreover, numerous attempts
to demonstrate eIF4G cleavage in vivo were unsuccessful.
In no case, eIF4G cleavage products were detectable.
These approaches included eIF4G analysis in HAV-
infected cells and after vaccinia virus-mediated over-
expression of HAV 3C
pro and its proteolytically active
precursor 3ABC. eIF4G was cleaved by CVB3 3C
pro that
was used as control, but not by HAV 3C
pro (Figure 1S, in
Supplementary Data). The resistance of eIF4G to HAV
3C
pro and its precursor-mediated cleavage clearly is in line
with the requirement of intact eIF4G for translation
initiation by the HAV IRES (33,55). As eIF4G cleavage
correlates with enteroviral cytopathology, lack of HAV
3C
pro-mediated eIF4G cleavage is also consistent
with the noncytolytic replication of HAV. Strikingly,
HAV IRES-dependent translation does not only require
complete eIF4G, but the entire eIF4F complex. This was
clearly evidenced by the ﬁnding that 4E-binding protein
interfered with HAV IRES activity, supposedly by
sequestrating eIF4E and preventing its interaction with
eIF4G (33). Moreover, addition of cap-analog blocked the
HAV IRES activity in vitro, indicating that translation
initiation by the HAV IRES requires association of eIF4E
with eIF4G and an empty cap-binding pocket of eIF4E
(55,56). Combined with earlier observations, all evidence
points to the notion that translation initiation by the HAV
IRES requires essentially the same translation factors as
capped host mRNAs and seems to compete with those
(2,27,55,56). This notion presents a surprising paradox
that the function of the 3’part of the HAV 50NTR in
translation is currently indistinguishable from cap-
dependent translation, although it folds into the con-
formation of a genuine IRES and mediates the expression
of a second cistron in a bicistronic construct (33).
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Figure 1. HAV 3C
pro cleaves PABP, but not eIF4G (A). The S10
extract of Huh-7 cells was incubated for 6h at 378C with HAV 3C
pro
and CVB3 3C
pro in vitro and eIF4G and PABP cleavage was analyzed
by immunoblot using anti-eIF4G (lower panel) or anti-PABP (upper
panel), respectively. Anti-PABP was raised against a synthetic peptide
sequence in the RRM4 of human PABP (63). Lane 1—no proteinase
added, lanes 2 and 3—the proteinases marked were added to a ﬁnal
concentration of 1.4mM. Products of PABP cleavage by HAV 3C are
marked with arrowheads, products of CVB3 3C with asterisks. eIF4G
indicates various cleavage products. (B). Concentration dependence of
HAV 3C cleavage in vitro of puriﬁed recombinant His-tagged PABP
(400ng). In lanes 1–4, the concentration of HAV 3C was 1, 2, 5 and
10mM, respectively. Anti-His was used to identify complete PABP and
its N-terminal cleavage products. (C) In vivo cleavage of recombinant
His-tagged PABP by HAV 3C precursors, both expressed in Huh-7
cells with the help of vaccinia virus vTF7-3. As described in the text,
proteolytically active 3ABCwt carries the wild-type sequence and
3ABCmut contains non-cleavable 3A/3B and 3B/3C junctions;
proteolytically inactive 3ABCm is mutated in the active site of 3C
pro
(C172A). The cleavage products were detected by anti-His. Note
that the N-terminally His-tagged 3C precursors were also detected
(empty arrow).
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not beneﬁt from the advantage that is usually supplied
by viral or cellular IRES.
HAV 3C
procleaves PABP
PABP is a translation initiation factor that together with
eIF4G forms a bridge between the 30 and 50 ends of
mRNA, including picornaviral RNA (2,3,5,8). The inter-
action between eIF4G and PABP is suﬃcient for mRNA
circularization (6). PABP cleavage has been implicated in
the cytopathic and apoptotic degeneration of infected and
non-infected cells (5,17). To investigate whether PABP is a
direct substrate of HAV 3C
pro, the same cleavage reaction
used to identify eIF4G cleavage products was analyzed by
immunoblot with anti-PABP (Figure 1A, upper panel).
Consistent with previously published data (17,18), CVB3
3C
pro partially cleaved PABP, resulting in three products
(lane 3, marked with asterisks). PABP cleavage by HAV
3C
pro generated two products (lane 2, marked with
arrowheads). The smallest HAV 3C cleavage product
migrated with the same mobility as the smallest cleavage
product of CVB3 3C
pro, suggesting that HAV 3C
pro also
cleaves near or at the dipeptide sequence (Q/T) of PABP
at position 415/416, which was proposed as site of
cleavage by enteroviral 3C
pro (18). Cleavage at this site
separates two essential functions of PABP: the NTD with
four RRMs binds RNA, whereas the CTD interacts with
various translation factors (5,7,9,10).
For poliovirus, it was demonstrated that initiation
factor- and ribosome-associated PABP was speciﬁcally
targeted by the viral proteinase in vitro, whereas non-
ribosome-associated PABP was mostly resistant to 3C
cleavage (18). However, no diﬀerence in PABP cleava-
bility by HAV 3C
pro was detectable when the S200 and
P200 (Ribo) fractions of Huh-7 cell extracts were
incubated with puriﬁed recombinant HAV 3C
pro
(Supplementary Figure 2S). Moreover, under no condi-
tion PABP cleavage in vivo was complete when CVB3 or
HAV 3C
pro was used, suggesting that compartimentaliza-
tion or an alternative conformation (PABP complexed
with proteins or RNA) may modulate PABP cleavage.
Notwithstanding, PABP cleavage by HAV 3C
pro was
further analyzed to ensure that PABP was a direct
substrate of HAV 3C
pro. For this, puriﬁed recombinant
PABP with an N-terminal His-tag was incubated for
various times (data not shown) or with increasing
concentrations of HAV 3C. In addition to anti-PABP
(data not shown), anti-His was used in the immunoblot, in
order to speciﬁcally demonstrate the N-terminal nature of
the cleavage products. As depicted in Figure 1B, puriﬁed
PABP with an N-terminal His-tag was almost completely
cleaved when HAV 3C
pro was used up to a 10mM
concentration (lanes 1–4). Again, two N-terminally
tagged cleavage products were detectable by anti-His
(marked by arrowheads). The cleavage products that were
derived from native and recombinant PABP and recog-
nized either by anti-PABP and/or anti-His were indis-
tinguishable (Figure 1A and B, respectively), implying that
they were C-terminally truncated.
In HAV-infected cells, 3C
pro co-exists with the
precursor polypeptide 3ABC that also shows proteolytic
activity with slightly diﬀerent substrate speciﬁcity (38,52).
To test whether this form of the viral proteinase was active
and yielded diﬀerent PABP cleavage products, proteo-
lytically active 3ABCwt and 3ABCm, with non-cleavable
3A/3B and 3B/3C junctions, were co-expressed with His-
tagged PABP and with the help of vaccinia virus vTF7-3.
Proteolytically inactive 3ABCm, which carries a mutation
at the active site of 3C
pro (C172A), was used as a control.
The expression and cleavage products were detected by
immunoblot with anti-His (Figure 1C). As expected,
3ABCm did not cleave PABP (lane 2). Both active
proteinases, 3ABCwt (lane 1) and 3ABCm (lane 3),
generated two PABP cleavage products in vivo
(arrowheads) that corresponded to those produced by
in vitro cleavage with the puriﬁed mature enzyme
(Figure 1A and B). The proteinase precursors with an
N-terminal His-tag were also detected in the blot (empty
arrow). Due to its autoproteolytic activity resulting in
3BC and 3C, lower amounts of unprocessed 3ABCwt
(lane 1) were found, as compared to either 3ABCm (lane 2)
or 3ABCm (lane 3). The data suggest that mature
proteinase 3C
pro and its precursor 3ABC have the same
PABP cleavage speciﬁcity.
In order to evaluate the extent of PABP cleavage in
HAV-infected cells, cell extracts of infected and non-
infected Huh-7 cells were analyzed by immunoblot with
anti-PABP (Figure 2). To correlate viral replication with
the extent of PABP cleavage, cell morphology was judged
by light microscopy and HAV particle formation was
determined in the same experiment. Compared to unin-
fected cells, no morphological changes were observed at
any time during viral replication, underlining the non-
cytopathogenic replication of HAV in this hepatoma cell
line (data not shown). Under the chosen infection
conditions, the small PABP cleavage product of 41kDa
(arrowhead) was detectable starting 9 days post-infection
(lane 6) when viral replication was actively proceeding.
The cleavage product detected in infected cells comigrated
with the polypeptide generated by PABP cleavage in vitro
with puriﬁed HAV 3C
pro and with the small cleavage
product of CVB 3C
pro (data not shown). Interestingly,
only the small PABP cleavage product was detected in
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Figure 2. PABP cleavage in HAV-infected Huh-7 cells. Clariﬁed lysates
of mock (lanes with odd numbers) and HAV-infected cells (lanes with
even numbers) obtained at the indicated days post-infection (dpi) were
separated by SDS–PAGE, transferred onto nitrocellulose membranes
and probed with anti-PABP. Viral antigen in the same extracts was
determined by ELISA and is presented below the lanes (+, antigenicity
3-fold; ++, 9-fold; +++, 20-fold; ++++ more than 30-fold over
negative ( ) controls).
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cleavage with recombinant 3C
pro (Figure 1). Although
viral particle accumulation still continued until the end of
the experiment (indicated below the lanes), the relative
small amount of the 41kDa PABP cleavage product
remained constant. Independent of the infectious dose
used, the extent of PABP cleavage was always low and
only detectable by the appearance of the cleavage product.
The highly limited PABP cleavage is in accordance with
the noncytolytic replication of HAV that does not shut oﬀ
host protein synthesis. Based on results shown below, we
speculate that HAV 3C
pro targets only those PABP
molecules that are bound to the viral poly(A) tail and
associated with the translation complex. It is expected that
the majority of PABP molecules, in particular those
involved in host protein translation, remains intact due to
inaccessibility to HAV 3C. It is also possible that the low
concentration or short half-life of 3C
pro in vivo is the
reason for the incomplete cleavage (57). Collectively, the
in vitro and in vivo cleavage data clearly show that PABP is
a direct substrate of HAV 3C
pro. Based on its electro-
phoretic mobility and compared with the PABP products
generated by enteroviral 3C cleavage, it can be concluded
that HAV 3C
pro removes the C-terminal third of PABP
that mediates PABP oligomerization and recruits proteins
involved in translation initiation and termination (18).
The exact locations of the HAV 3C cleavage sites within
PABP await sequence analysis.
Functional role of C-terminally truncated PABP
Apparently PABP cleavage in HAV-infected cells is
strictly limited to a particular portion of PABP
molecules, suggesting that HAV 3C
pro-mediated cleavage
might support a viral function rather than concern host
translation. Possibly, HAV 3C
pro is only active on PABP
molecules associated with the viral poly(A) tail. In fact,
only a small portion of the viral genomes appears to be
unpackaged and translationally active in HAV-infected
cells (58). In the next experiments, we tested the recently
proposed hypothesis that 3C
pro cleavage of PABP might
be a precondition for viral translation arrest (5). Similar
to studies described elsewhere, transcripts containing the
ﬁreﬂy luciferase preceded by the HAV IRES were
translated in vitro using either the reticulocyte lysate
(data not shown) or S10 extract that were pretreated with
HAV 3C
pro (27). As under the experimental conditions
used, not only PABP, but also PCBP and PTB were
found to be cleaved, the eﬀect of cleaved PABP on HAV
translation could not be singled out under this experi-
mental condition (data not shown). To evade the
unintended cleavage of host proteins, we next tested
the eﬀect of puriﬁed NTD added to in vitro translation
reactions primed with synthetic transcripts representing
the HAV and PV replicon. The S10 extract of Huh-7
cells was supplemented with puriﬁed PABP, NTD and
CTD and IRES translation was monitored by the
reporter gene activity. Cap-independent translation of
the HAV replicon was mostly unaﬀected by the addition
of intact PABP or CTD (Figure 3A, bars 3 and 4), but
inhibited when NTD was present (bar 2). In the assays,
the NTD and CTD concentration was 0.3mM and thus
in the range of endogenous PABP (9). Under the same
conditions, translation of the PV replicon RLuc31 was
two times higher (right ordinate) and no suppression was
observed (Figure 3A, lanes 5–8). The inhibitory eﬀect of
NTD on HAV IRES translation was also detectable
when a synthetic transcript derived from pHAV-IRES-
luc and containing the ﬁreﬂy luciferase preceded by the
HAV IRES was expressed in the S10 extract (Figure 3B).
In this experiment, the eﬀect of native NTD was
normalized by that of the heat-denatured protein set at
100%. Under these experimental conditions, NTD at
concentrations equal to and higher than 0.3mM speciﬁ-
cally suppressed the function of the HAV IRES. No
eﬀect was observed when CTD was added to the system
(data not shown). These ﬁndings clearly demonstrate that
the N-terminal domain of PABP has a dominant
negative eﬀect on HAV IRES-mediated translation.
They suggest that NTD might either change the
conformation of the HAV IRES or of eIF4G or compete
with eIF4G for binding to the IRES.
Figure 3. Eﬀect of PABP and its NTD and CTD on HAV and PV
IRES translation. (A) In vitro expression of the HAV (bars 1–4 and left
ordinate) and PV replicon RNA (bars 5–8 and right ordinate). The
translation of the luciferase reporter gene was analyzed in S10 extracts
supplemented with PABP (bars 1 and 5), NTD (bars 2 and 6), CTD
(bars 3 and 7) or buﬀer (bars 4 and 8). (B) In vitro expression of RNA
HAV-IRES-Luc in S10 extracts supplemented with increasing concen-
trations of native and heat-denatured NTD. Luciferase activity (RLU)
in the presence of native NTD was normalized to the activity
determined in the presence of denatured protein.
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HAV IRES-dependent translation competes with and
precludes subsequent negative strand RNA synthesis on
the same RNA molecule. For PV, several viral and host
proteins in association with viral 50 terminal RNA
structures were proposed to be involved in RNA template
switching from translation to replication (5,34,59–61). In
particular, cleavage of RNA-binding host proteins
(PABP, PCBP, PTB, La autoantigen) might be implicated
in this regulatory step (5,60,61). In line with this concept,
we were interested to search for a positive role of NTD in
HAV RNA synthesis. So far, no in vitro system is
available to directly study HAV genome replication. As
binding to terminal RNA structures of the viral genome is
an essential prerequisite for the role of a host or viral
protein and therefore a surrogate feature for RNA
synthesis, we compared the binding speciﬁcities and
aﬃnities of PABP and NTD to terminal RNA elements
of the HAV genome. In this context, it is also interesting
to note that biosynthesis of PABP is inhibited by
autoregulatory binding of PABP to the 50NTR of its
own mRNA (62).
The functionality and speciﬁcity of complete and
truncated recombinant PABP was ﬁrst determined by
their interaction with the HAV 30 NTR, using EMSAs.
The apparent equilibrium-binding constant (app. Keq) was
determined in additional titration experiments (data not
shown). No binding of recombinant PABP to the HAV 30
NTR lacking the poly(A) tail was observed (Figure 4A,
lanes 1–4, app. Keq>>10mM). Ribonucleoprotein (RNP)
complex formation was seen when the RNA ligand
contained a poly(A) tail of 14 (data not shown) or 20
residues (lanes 5–9, app. Keq=0.05mM). PABP binding
to the 30NTR was even more enhanced when the poly(A)
tail comprised 60 residues (lanes 10–13, app.
Keq<0.05mM). This app. Keq was similar to what has
been reported for the 30NTR of PV with a poly(A) tail of
80nt (60). As expected, binding of multiple copies of
PABP to the poly(A) tail was noticeable by the formation
of RNPs with diﬀerent mobilities. The NTD of PABP also
interacted with the polyadenylated HAV 30NTR, yet
somewhat less eﬃciently (data not shown). Our results
conﬁrm the notion that cooperative PABP binding to the
HAV 30NTR is dependent on the poly(A) tail length and
that binding requires the N-terminal RRMs of PABP.
Surprisingly, initiation of enteroviral negative strand
RNA synthesis is regulated by cis-acting RNA elements
present at the distant 50 end of the positive strand RNA
genome (34,42,59). Moreover, a protein bridge formed by
PCBP and PABP was proposed to be required for PV
negative strand synthesis (60). In line with such a model,
we were interested to test the possibility that C-terminally
truncated PABP might be directly involved in a replication
function mapping to the HAV 50NTR. Both RNA
structural elements comprising bases 1–94 and 95–148
(pY1) were previously found to be essential for HAV
RNA synthesis (26) and were therefore tested for
their direct interaction with PABP and NTD. Whereas
RNA1–94 did not directly bind to either complete or
C-terminally truncated PABP (Figure 4B, lanes 1–3),
incubation of puriﬁed NTD with radiolabeled pY1 yielded
a RNP that was discernable by EMSA (lanes 4–6). In
contrast to PABP (lane 5), NTD at the same concentra-
tion (0.7mM) was able to shift the mobility of pY1
(lane 6). Based on the relative app. Keq that was calculated
for PABP and NTD, it was concluded that NTD was  10
times more eﬃcient in binding pY1 (see Supplementary
Figure 3S). The data indicate that removal of the CTD
from PABP-enhanced binding to pY1 in the HAV 50NTR,
a structure pivotal in virus replication. Although spec-
ulative, the data provide the basis for the hypothesis that
PABP cleavage mediated by HAV 3C
pro might be
involved in HAV template switching from translation to
genome replication.
In summary, we report that HAV 3C
pro cleaves PABP,
which was shown to mediate the synergistic eﬀect of the
poly(A) tail on IRES-dependent translation and substan-
tially enhance protein synthesis (1–3). We also show that
the N-terminal fragment of PABP inhibits HAV IRES-
dependent translation (Figure 3) and has an enhanced
binding capacity to pY1 (Figures 4 and 3S). Based on
these new ﬁndings and a model proposed for poliovirus
Figure 4. Interaction of PABP and NTD with RNA structures at the
30 and 50 end of the HAV genome. (A) PABP interaction with the HAV
3’NTR without or with a poly(A) tail of diﬀerent lengths (A20 and A60
as indicated above the lanes). Puriﬁed PABP was incubated in
increasing concentrations (indicated above the lanes) with radiolabeled
RNA and RNP complex formation was analyzed by EMSA on a native
polyacrylamide gel. (B) Diﬀerential-binding capacity of PABP and
NTD. Complex formation of PABP and NTD (both 0.7mM) with
RNA1-94 (lanes 1–3) and pY1 (RNA95–148) (lanes 4–6) was assessed
by EMSA. Mobility of the free RNAs is marked on the left; the
RNA–protein complexes are marked on the right.
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PABP cleavage in HAV RNA template switching
(Figure 5). In contrast to poliovirus that shuts oﬀ host
translation by cleaving eIF4G, HAV translation
constantly competes with host translation for initiation
factors (e.g. eIF4G) and is therefore highly ineﬃcient
(1,36,37). After adequate amounts of translation and
polyprotein processing products have accumulated, PABP
bound to the HAV poly(A) tail is speciﬁcally targeted by
HAV 3C
pro. In contrast to the complete protein, the
resulting poly(A) bound N-terminal cleavage product of
PABP (NTD) no longer bridges the poly(A) tail to the
IRES, but rather to the 50RNA structure pY1, which was
shown to be essential for viral replication (26). As a
consequence, ribosomes cease to recycle in order to initiate
HAV IRES translation. Subsequently, stalled protein
synthesis gives way to viral RNA synthesis that uses the
same RNA template as translation, yet in the opposite
direction. To better understand the exact molecular
mechanisms, in particular the possible involvement of
other viral and/or cellular components, further studies are
needed. Not depicted in our model is the possibility that
truncated PABP sequesters and/or modiﬁes the functional
conformation eIF4G, such that ribosome re-initiation at
the 50IRES structure is no longer possible. As—to our
current knowledge—the major components needed for
HAV IRES-dependent translation are the same as for cap-
dependent host translation (56), it is likely that the model
proposed for cellular translation arrest (5) holds also true
for HAV translation and provides an example for the
delicate viral–host interplay to the best of both partners.
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